Go to Login or Register to make a submission.

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • Authors may suggest up to 4 peer reviewers per submission.
  • Please include at least two potential peer reviewers for your article. Include suggested reviewer name and contact information

PLEASE NOTE: Authors must first register through this submission page in-order to upload manuscripts, and track submission process.  If you are having trouble registering, please contact Scott Bryant, Managing Editor; sbryant@dougmargroup.com. Information used to register as an author will only be used for the purposes of manuscript tracking and submission purposes.


Author Processing Charges

Please note that starting January 1, 2018 the Journal of Population Therapeutics and Pharmacology (JPTCP) will charge an Author Processing Fee (APC) of US $995. Articles will go through a thorough peer review process, benefit from high quality editing, and will be posted on-line for greater exposure, within 60 days of acceptance. Articles are archived on the journal web site and through Portico. All articles/information will also be included in PubMed data base, Emerging Sources Citation Index, Scopus, EMBASE, CrossRef


INSTRUCTIONS TO AUTHORS: Journal of Population Therapeutics and Clinical Pharmacology 

MANUSCRIPT PREPARATION. Arrange the manuscript as follows: title page, structured abstract and key words, introduction, methods, results, discussion, acknowledgments, references, figure legends, tables and figures. The text portion of the manuscript from title page to references should be in one electronic editable file (not as a PDF file), Tables and Figures can be embedded or included in a separate file.

TITLE PAGE: Include the title, authors' names, degrees, and the author's institutional affiliations. Under a heading of 'Corresponding Author' provide the full name, exact mailing address with postal code, telephone and fax numbers, and e-mail address of the author to whom communication and proofs should be sent.

KEY WORDS: At the end of the abstract, include a list of two to six key words and subjects for indexing purposes.

HEADINGS/SUBHEADINGS: Please provide methods, results and discussion sections. References, figures and tables should be cited in the text with numbers assigned according to the order of mention in the text. Brief acknowledgments may appear at the end of the text, before the references.

SYMBOLS AND ABBREVIATIONS: Use only standard abbreviations; the use of non-standard abbreviations can be extremely confusing to readers. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. See list of NCBI Standard Acronyms and Abbreviations.

ACKNOWLEDGMENTS AND FUNDING: Individuals who contributed significantly to the research or preparation of the manuscript may be acknowledged in this section, in italics. When this is done, a cover letter can indicate that all those named have given their permission. Provide information concerning grants, contracts and other forms of financial support and the name(s) of the institution(s)at which the work originated.

REFERENCES: Personal communications, manuscripts in preparation and other unpublished data are not cited in the reference list but may be mentioned in the text in parentheses. Identify references in the text by Arabic numerals in suprascript on the line. References should be typed, double-spaced, separate from the text and numbered consecutively in the order in which they are mentioned in the text. (References cited in figures and tables, but not in the text, should be numbered consecutively following the text references.)

Please do NOT format references as 'endnotes' in the main document.

Journal references should contain inclusive page numbers; book references specific page numbers; and website references the author's name, title of document, uniform resource locator and date of access (references to other types of electronic documents should include format of the document). Indicate abstracts by the abbreviation 'Abst', and letters by 'Lett' in parentheses. Abbreviations of journals should conform to those used in Index Medicus, National Library of Medicine. The style and punctuation of references are as follows:

Periodicals: List all authors if 4 or fewer; otherwise list first three and add 'et al'. Do not use periods after authors' initials.

12. Piafsky KM, Sitar DS, Rangno RE, et al. Theophylline disposition with hepatic cirrhosis. N Engl J Med 1977;296:1495-7.

Books - Example: 14. Prober CG, Gold R. Antimicrobial Therapy in Infants and Children. New York: Marcel Dekker, 1993.

Chapter in book - Example: 21. Richer M, LeBel M. Pharmacokinetics of fluoroquinolones in selected populations. In: Hooper DC, ed. Quinolone Antimicrobial Agents. Washington: ASM Publications, 1993:225-244.

Website - Example: National Library of Medicine. Images from the History of Medicine.(May 1, 1997) http://wwwihm.nlm.nih.gov/ (accessed on: January 5, 1999).

FIGURE LEGENDS: Numbered corresponding to the order in which figures are presented in the text. Identify all abbreviations appearing on figures in alphabetical order at the end of each legend. Enough information should be given to allow interpretation of the figure without reference to the text. Written permission must be obtained from the publisher to reproduce any previously published figures. Cite the source of the figure in the legend. Figure legends should not appear on the actual figures.

TABLES: Table numbers should appear in Arabic numerals and should correspond to the order of the tables in the text. Footnote each table with an alphabetical listing of all abbreviations used. Ensure that tables are self-explanatory and that the data are not duplicated in the text. Written permission from the publisher to reproduce any previously published tables must be included. Tables must be in an editable format and not a pdf.

FIGURES: The lettering on the figures should be sufficiently large to withstand reduction. Decimals, lines and other details must be bold enough for reproduction. Figures are limited to the number necessary for clarity.

CONFLICT OF INTEREST GUIDELINES: Sources of funding should be acknowledged, and all authors must disclose any commercial associations or other arrangements (e.g., financial compensation, potential to profit, consultancy, stock ownership, honoraria, patent-licensing arrangement, etc.) that might pose a conflict of interest in connection with the submitted article. Some or all of this information will be made available to the reviewers and, at the discretion of the editor, may be published in a footnote to the article.

ABSTRACTS: Abstracts should be structured (as illustrated below) and no more than 250 words for major articles (including review articles). Abstracts for case reports need not be structured, but are limited to 150 words. The abstract should be substantive rather than purely descriptive. Abbreviate only standard units of measurement. Tables, photos and figures will NOT be included as part of an abstract.

Sample Abstract:

Title: The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels

Author: Ali F, Laurin M-Y, Larivire C, Tremblay D, Cloutier D

Background: Dyslipidemias are a modifiable risk factor for coronary heart disease. The benefits of cholesterol reduction drug therapies are limited by poor patient compliance with drug regimens.

Objectives: To determine the impact of a community pharmacist pilot disease-management program on patient compliance with lipid-lowering drug therapy and on serum cholesterol levels.

Methods: One hundred forty-nine patients who were nonadherent to prescribed hypolipidemic drug regimens were recruited for this six-month prospective study. Each subject served as their own control. Pharmacists educated these patients on lipid disorders, the benefit of medication compliance and lifestyle modifications that reduce the risk for coronary heart disease. Pharmacists followed up participants by telephone at two-month intervals. Drug renewal rates were monitored throughout the study and plasma lipid levels were measured at study outset and study end.

Results: Pharmacist intervention and patient-education programs significantly increased medication compliance, as shown by a 15.3% increase (P>0.05) in the number of compliant patients and an 11 day (P>0.001) reduction in the average number of days to prescription renewal. Concurrently, levels of total cholesterol, triglycerides and low-density lipoprotein (LDL) cholesterol, were reduced by 6%, 16.2%, and 8.5% (P>0.001, 0.01, 0.01), respectively. High density lipoprotein (HDL) cholesterol remained relatively unchanged (+0.7%) so that the LDL to HDL ratio was improved by 7.2% overall (P>0.01). Almost all of the patients (99.2%) were satisfied with the program and expressed a willingness to pay an average $34.50 per 30 min consultation for the pharmacist services offered.

Conclusion: Pharmacists can contribute significantly to disease management of dyslipidemic individuals.

Key Words: Compliance, disease management, lipid-lowering therapy

For questions, please contact Managing Editor through email - sbryant@dougmargroup.com 

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.